CoChat

Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia

Open access
Kuo, Chian-Jue, Yang, Shu-Yu, Liao, Ya-Tang, Chen, Wei J., Lee, Wen-Chung, Shau, Wen-Yi, Chang, Yao-Tung, Tsai, Shang-Ying, Chen, Chiao-Chicy · 2013 · Schizophrenia Bulletin
Cited by 156

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

This study assessed the association between second-generation antipsychotic medications and risk of pneumonia requiring hospitalization in patients with schizophrenia because the evidence is limited in the population. We enrolled a nationwide cohort of 33,024 inpatients with schizophrenia ranged in age from 18 to 65 years, who were derived from the National Health Insurance Research Database in Taiwan from 2000 to 2008. Cases (n = 1741) were defined as patients who developed pneumonia after their first psychiatric admissions. Risk set sampling was used to match each case with 4 controls by age, sex, and the year of the first admission based on nested case-control study. Antipsychotic exposure was categorized by type, duration, and daily dose, and the association between exposure and pneumonia was assessed using conditional logistic regression. We found that current use of clozapine (adjusted risk ratio = 3.18, 95% CI: 2.62-3.86, P < .001) was associated with a dose-dependent increase in the risk. Although quetiapine, olanzapine, zotepine, and risperidone were associated with increased risk, there was no clear dose-dependent relationship. Amisulpride was associated with a low risk of pneumonia. The use of clozapine combined with another drug (olanzapine, quetiapine, zotepine, risperidone, or amisulpride), as assessed separately, was associated with increased risk for pneumonia. In addition, with the exception of amisulpride, each drug was associated with increased risk for pneumonia at the beginning of treatment. Clinicians who prescribe clozapine to patients with schizophrenia should closely monitor them for pneumonia, particularly at the start of therapy and when clozapine is combined with other antipsychotics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/schbul/sbr202

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 156

Metadata

Authors
Kuo, C.-J., Yang, S.-Y., Liao, Y.-T., Chen, W. J., Lee, W.-C., Shau, W.-Y., Chang, Y.-T., Tsai, S.-Y., & Chen, C.-C.
Venue
Schizophrenia Bulletin
Published
2012-01-26
Volume
39
Issue
3
Pages
648-657
ISSN
  • 0586-7614 (ISSN-L)
  • 1745-1701
OpenAlex
W2120839494
Cited by
156
References
5
FWCI
4.51
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia. https://app.cochat.ai/papers/10.1093/schbul/sbr202
The paper
Kuo, C.-J., Yang, S.-Y., Liao, Y.-T., Chen, W. J., Lee, W.-C., Shau, W.-Y., Chang, Y.-T., Tsai, S.-Y., & Chen, C.-C. (2013). Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbr202

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.